What is the current Price Target for the Immunome Inc stock?

The average Immunome Inc target price is $36.72. This is 69.37% higher than the current stock price. The highest price target is 93.73%, the lowest is 39.76%. 15 Analysts have issued a price target Immunome Inc 2027 .

How high will the Immunome Inc stock rise?

No reliable answer can be given as to how high the Immunome Inc stock will rise. The performance of stocks, including the Immunome Inc stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Immunome Inc stock today?

The performance of Immunome Inc stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Immunome Inc stock fall?

The decline in Immunome Inc stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Immunome Inc Forecast, price target & analysts

$21.71

0.14%

Nasdaq, Sep 29, 10:25 am EDT. Market open.

ISIN

US45257U1088

Symbol

IMNM

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Overview Analysts Charts Ownership News Strategies

Immunome Inc Target price 2026 - Analyst rating & recommendation

Immunome Inc Classifications & Recommendation

Buy

95%

Hold

Immunome Inc Price Target

Target Price	$36.72
Price	$21.68
Potential	69.37% register free of charge
Number of Estimates	15

	15 Analysts have issued a price target Immunome Inc 2027 . The average Immunome Inc target price is $36.72. This is 69.37% register free of charge higher than the current stock price. The highest price target is $42.00 93.73% register free of charge , the lowest is $30.30 39.76% register free of charge .
	A rating was issued by 20 analysts: 19 Analysts recommend Immunome Inc to buy, 1 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Immunome Inc stock has an average upside potential 2027 of 69.37% register free of charge . Most analysts recommend the Immunome Inc stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '25	2026 Estimates
Earnings Per Share $	-2.43	-2.42
	51.40%	0.41%
P/E		negative
EV/Sales		5,712.88

16 Analysts have issued a Immunome Inc forecast for earnings per share. The average Immunome Inc EPS is

unlock

. This is

unlock

than earnings per share in the financial year 2025. The highest EPS forecast is

unlock

, the lowest is

unlock

This results in the following potential growth metrics and future valuations:

2025	$-2.43	51.40%
2026	$-2.42 0.41% unlock
2027	$-2.58 6.61% unlock
2028	$-1.56 39.53% unlock
2029	$0.42 126.92% unlock
2030	$1.62 285.71% unlock
2031	$2.72 67.90% unlock
2032	$3.54 30.15% unlock
2033	$4.59 29.66% unlock

Current	-9.68	103.76%
2026	-8.95 7.53% unlock
2027	-8.41 6.03% unlock
2028	-13.86 64.80% unlock
2029	51.34 470.42% unlock
2030	13.42 73.86% unlock
2031	7.98 40.54% unlock
2032	6.12 23.31% unlock
2033	4.72 22.88% unlock

Immunome Inc...

Current Immunome Inc Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
Alliance Global Partners	Locked ➜ Locked	Locked	Sep 21 2026
HC Wainwright & Co.	Locked ➜ Locked	Locked	Sep 10 2026
Wedbush	Locked ➜ Locked	Locked	Aug 12 2026
Truist Securities	Locked ➜ Locked	Locked	Aug 12 2026
Wedbush	Locked ➜ Locked	Locked	Jul 21 2026
Wedbush	Locked ➜ Locked	Locked	Jun 12 2026
Barclays	Locked ➜ Locked	Locked	May 28 2026

Analyst Rating	Date
Locked Alliance Global Partners: Locked ➜ Locked	Sep 21 2026
Locked HC Wainwright & Co.: Locked ➜ Locked	Sep 10 2026
Locked Wedbush: Locked ➜ Locked	Aug 12 2026
Locked Truist Securities: Locked ➜ Locked	Aug 12 2026
Locked Wedbush: Locked ➜ Locked	Jul 21 2026
Locked Wedbush: Locked ➜ Locked	Jun 12 2026
Locked Barclays: Locked ➜ Locked	May 28 2026

Discover more stocks with a high price target

NIO ADR 104.00%

Alibaba Group Holding Ltd 73.67%

Rheinmetall 68.89%

Infineon 63.18%

Tencent Holdings Ltd. 58.19%

Adyen 55.40%

TUI 52.20%

BYD 51.64%

Uber Technologies 51.14%

Siemens Energy 48.42%

Adidas 41.08%

Netflix 39.97%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now